Stage IVA Oropharyngeal Squamous Cell Carcinoma Recruiting Phase 2 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0039579 (Stage IVA Oropharyngeal Squamous Cell Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02734537Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryTreatment